ALPINE IMMUNE SCIENCES, INC. Quarterly Interest Expense in USD from Q1 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Alpine Immune Sciences, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2014 to Q1 2024.
  • Alpine Immune Sciences, Inc. Interest Expense for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
  • Alpine Immune Sciences, Inc. Interest Expense for the twelve months ending March 31, 2024 was $28K, a 92.9% decline year-over-year.
  • Alpine Immune Sciences, Inc. annual Interest Expense for 2023 was $98K, a 79.4% decline from 2022.
  • Alpine Immune Sciences, Inc. annual Interest Expense for 2022 was $476K, a 41.7% decline from 2021.
  • Alpine Immune Sciences, Inc. annual Interest Expense for 2021 was $816K, a 5.29% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $28K $0 -$70K -100% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $98K $0 -$87K -100% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 $185K $0 -$105K -100% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $290K $28K -$102K -78.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $392K $70K -$84K -54.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $476K $87K -$91K -51.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 $567K $105K -$98K -48.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $665K $130K -$88K -40.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $753K $154K -$63K -29% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $816K $178K -$37K -17.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-20
Q3 2021 $853K $203K -$11K -5.14% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $864K $218K -$8K -3.54% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $872K $217K +$97K +80.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $775K $215K +$74K +52.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 $701K $214K +$148K +224% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $553K $226K +$165K +270% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $388K $120K +$50K +71.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $338K $141K +$65K +85.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-17
Q3 2019 $273K $66K -$16K -19.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $289K $61K -$22K -26.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $311K $70K -$8K -10.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $319K $76K $0 0% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-18
Q3 2018 $319K $82K +$7K +9.33% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $312K $83K +$82K +8200% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $230K $78K +$78K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $152K $76K Oct 1, 2017 Dec 31, 2017 10-K 2020-03-30
Q3 2017 $75K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $1K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2014 $845K $0 Oct 1, 2014 Dec 31, 2014 10-K 2017-02-13
Q3 2014 $392K Jul 1, 2014 Sep 30, 2014 10-K 2016-03-08
Q2 2014 $241K Apr 1, 2014 Jun 30, 2014 10-K 2016-03-08
Q1 2014 $212K Jan 1, 2014 Mar 31, 2014 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.